Skip to main content
GameRevenueData

Publisher

Games Published by SOULCHAN: Revenue & Sales Estimates

Revenue estimates for the 9 Steam games published by SOULCHAN, ranked by estimated net revenue. Available estimated lifetime net (USD): $2.4K.

Catalog Est. Lifetime Net (USD)

$2.4K

Estimates for 2 of 9 tracked games

Tracked games

9

Top Earner

Ramune's Square Dungeon

$1.5K

Coverage: 9 tracked titles; 2 with net estimates; 7 without. 0 have dedicated profiles. Missing estimates are excluded from the aggregate, not treated as known zero revenue.

Role: Publisher. These are lifetime estimates for games credited to SOULCHAN; they are not company earnings, profit, or contractual receipts. Credits may omit co-development or historical publishing arrangements. Developer and publisher identities are not merged by matching names.

Recorded release dates: 2024-06-13–2025-10-13 (may include announced dates).

Largest title accounts for 62.7% of available estimated net revenue. Coverage gaps can change this share.

Showing 1–9 of the top 9 displayed entries, from 9 tracked titles. Figures include only available estimates. Search the full catalog .

Rows 1–9 · Page 1 of 1

# Game Est. lifetime net (USD) Positive reviews (raw) Release
1 Ramune's Square Dungeon $1.5K 100%Positive (22) Apr 17, 2025
2 FROG vs Mural Girl 2 The back Layer $897 97%Positive (39) Jul 29, 2025
3 MOMOCHIYO'S MONONOKETAIJI 90%Positive (10) Jun 13, 2024
4 ダンジョンビーチ (0) Aug 2, 2024
5 FART BUBBLE DX 80%Positive (5) Oct 21, 2024
6 Kapuritto-kyu Minigame Collection 100%Positive (5) Mar 12, 2025
7 FART DROP DX 100%Positive (9) Jun 14, 2025
8 FROG vs Dragon Girl 100%Positive (3) Oct 13, 2025
9 FROG vs Mural Girl 3 The Crossroad (0)

Get real-time dashboards, historical trends, and AI-powered analysis

Explore on PlayRev(opens in new tab)

Revenue and sales estimates are based on the Boxleiter method using publicly available data including Steam review counts, pricing history, and statistical modeling. Actual revenue may differ significantly. These figures are provided for informational purposes only and should not be used for financial decisions. Read the full methodology.